LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals
LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals
LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
OECD SIDS <strong>LINEAR</strong> <strong>ALKYLBENZENE</strong> <strong>SULFONATE</strong> (<strong>LAS</strong>)<br />
LOAEL: 500 mg/kg bw d in diet<br />
Results: In the mice given 0.6% in their diet, body weight gain was not suppressed,<br />
but the weight of the liver increased in male and female mice. Enzymatic<br />
examinations revealed significant decreases in LDH of the liver and in acid<br />
phosphatase of the kidneys in the male mice. For mice given <strong>LAS</strong> in<br />
drinking water, body weight was depressed at the highest dose for males and<br />
females. This dose also elicited an increase in liver weight in females and<br />
significant decreases in renal Na and K-ATPase.<br />
Method: Groups of 8 or 9 mice were given diets containing <strong>LAS</strong> at concentrations of<br />
0.6 and 1.8% or drinking water containing <strong>LAS</strong> at concentrations of 0.07,<br />
0.2, and 0.6% for 9 months.<br />
GLP: Yes [ ] No [X] ? [ ]<br />
Test substance: <strong>LAS</strong><br />
Reference: 1) European Commission. 2000a. Benzenesulfonic acid, C10-13-alkyl derivs.,<br />
sodium salts. Year 2000 CD-ROM edition.<br />
2) Yoneyama, M., Mabuchi, Y., Ikawa, M., Kobayashi, H. and Ichikawa, H.<br />
1976. Subacute toxicity of linear alkylbenzene sulfonate. Ann. Rep. Tokyo<br />
Metr. Res. Lab. P.H. 27(2):105-112 (in Japanese); cited in: IPCS (1996);<br />
Environmental Health Criteria 169: Linear Alkylbenzene Sulfonates (<strong>LAS</strong>)<br />
and Related Compounds. WHO, Geneva, Switzerland.<br />
3) HERA. 2002. HERA-<strong>LAS</strong> Human and Environmental Risk Assessment:<br />
Linear Alkylbenzene Sulphonates, <strong>LAS</strong>. CAS No. 68411-30-3, Draft #6,<br />
May 2002.<br />
Reliability: 4 This study is assigned a reliability score of 4 because the original report<br />
was not available for review. However, the study was evaluated by IPCS<br />
prior to inclusion in their criteria document.<br />
(k)<br />
Species/strain: Rat: Charles River<br />
Sex: Female [ ]; Male [ ]; Male/Female [X]; No data [ ]<br />
Administration: oral feed<br />
Exposure period: 2 years<br />
Frequency of treatment:continuous in feed<br />
Doses: 0.02, 0.1, 0.5% (10, 50, 250 mg/kg bw d)<br />
Control group: Yes [X]; No [ ]; No data [ ];<br />
Concurrent no treatment [ X]; Concurrent vehicle [ ]; Historical [X]<br />
Results: Gross examination of all animals for pathology did not reveal any<br />
abnormalities. No consistent dietary induced changes that could be<br />
considered a toxic response were observed. Animals that showed significant<br />
loss of weight, development of tumors, or other evidence of abnormalities<br />
were sacrificed and tissues examined. The incidence of tumors and the<br />
common incidental diseases were similar in all dieting groups. No treatmentrelated<br />
adverse histological effects were observed in any of the tissue sections<br />
examined.<br />
Method: Four groups of Charles River weanling rats, divided by sex, were given 0.5,<br />
0.1, and 0.02% <strong>LAS</strong> in their food for 2 years. Following completion of those<br />
studies, five male and five female rats from each of the parental groups (F1b<br />
and F2b) and all survivors were selected for necropsy. Livers and kidneys<br />
were removed and weighed. Body weight and organ to body weight ratios<br />
were recorded, and routine hematology and histology were performed.<br />
Sections for histological examination were taken from the liver, kidney,<br />
thyroid, trachea, esophagus, lung, heart, spleen, pancreas, adrenals, stomach,<br />
small intestine, urinary bladder, gonads and mesenteric lymph nodes.<br />
Weanling animals for the F3a generation were similarly treated.<br />
GLP: Yes [ ] No [X] ? [ ]<br />
<strong>UNEP</strong> PUBLICATIONS 277